They work with our development partners to ensure that the formulation of the finished product is regulatory accepted worldwide wherever possible.

When developing FDFs, this requires validated manufacturing processes as well as the use of recognised quality principles (GMP, GDP) and efficient control methods to assess the development and documentation status of drug projects (due diligence) for possible in-licensing.

Of course, new products should also be reproducible in an economic way – therefore, the consideration of the complete life cycle from industrial production to testing, storage and distribution of the product is just as much a part of the tasks of product development as the compilation of all approval documents as well as the necessary summaries and the comparison of compliance with the relevant regulations.